Users may experience increased energy levels, improved sleep quality, reduced appetite, and enhanced mood
Quality peptide synthesis is expensive
The MHRA has approved specific GLP-1 receptor agonists for weight management (Wegovy and Saxenda) in individuals with a body mass index (BMI) of 30 kg/m or above, or 27 kg/m with weight-related comorbidities, while others are approved only for glycaemic control in type 2 diabetes
Regular resistance training, hydration, recovery optimization, and sleep quality can further enhance growth hormonemediated pathways and support long-term musculoskeletal health
Khavinsons work focused on extracting bioactive compounds from the pineal gland, leading to the identification of naturally occurring peptides that appeared to influence aging processes